ENTPD1 and neoplasm: The majority of tumour reactive CTL in the tumour microenvironment (TME) show characteristics of T cell exhaustion including high levels of PD-1 alongside multiple co-inhibitory markers including CTLA-4, Tim3, GITR and CD39 (5).